 | • レポートコード：MRC2012B0533 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、免疫細胞療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。免疫細胞療法の種類別市場規模（パッシブ免疫（NK、LAK、その他）、アクティブ免疫）、用途別市場規模（腫瘍、心血管疾患（CVD）、整形外科、創傷治癒、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：MEDINET Co、Gilead Sciences、Takeda、Erytech、Fate Therapeutics、Seta Clinic Group、Osiris、Oxford BioTherapeutics、SBI Holdings、Novartis、Golden Meditech、Vericel Corporation、Guanhao Biotech、Beike Biotechnology、Fujifilm Cellular Dynamics、Beroni Group、JCR Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・免疫細胞療法の北米市場（アメリカ、カナダ、メキシコ） ・免疫細胞療法のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・免疫細胞療法のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・免疫細胞療法の南米市場（ブラジル、アルゼンチン） ・免疫細胞療法の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：パッシブ免疫（NK、LAK、その他）、アクティブ免疫 ・用途別分析：腫瘍、心血管疾患（CVD）、整形外科、創傷治癒、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Immuno-Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Immuno-Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Immuno-Cell Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Immuno-Cell Therapy market has been segmented into:
Passive Immune (NK, LAK etc)
Active Immune
By Application, Immuno-Cell Therapy has been segmented into:
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Immuno-Cell Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Immuno-Cell Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Immuno-Cell Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Immuno-Cell Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Immuno-Cell Therapy Market Share Analysis
Immuno-Cell Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Immuno-Cell Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Immuno-Cell Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Immuno-Cell Therapy are:
MEDINET Co
Gilead Sciences
Takeda
Erytech
Fate Therapeutics
Seta Clinic Group
Osiris
Oxford BioTherapeutics
SBI Holdings
Novartis
Golden Meditech
Vericel Corporation
Guanhao Biotech
Beike Biotechnology
Fujifilm Cellular Dynamics
Beroni Group
JCR Pharmaceuticals
Among other players domestic and global, Immuno-Cell Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Immuno-Cell Therapy Market Overview
1.1 Product Overview and Scope of Immuno-Cell Therapy
1.2 Classification of Immuno-Cell Therapy by Type
1.2.1 Global Immuno-Cell Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Immuno-Cell Therapy Revenue Market Share by Type in 2019
1.2.3 Passive Immune (NK, LAK etc)
1.2.4 Active Immune
1.3 Global Immuno-Cell Therapy Market by Application
1.3.1 Overview: Global Immuno-Cell Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiovascular Disease (CVD)
1.3.4 Orthopedic
1.3.5 Wound Healing
1.3.6 Others
1.4 Global Immuno-Cell Therapy Market by Regions
1.4.1 Global Immuno-Cell Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Immuno-Cell Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Immuno-Cell Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Immuno-Cell Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immuno-Cell Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Immuno-Cell Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immuno-Cell Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 MEDINET Co
2.1.1 MEDINET Co Details
2.1.2 MEDINET Co Major Business
2.1.3 MEDINET Co SWOT Analysis
2.1.4 MEDINET Co Product and Services
2.1.5 MEDINET Co Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences SWOT Analysis
2.2.4 Gilead Sciences Product and Services
2.2.5 Gilead Sciences Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda SWOT Analysis
2.3.4 Takeda Product and Services
2.3.5 Takeda Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Erytech
2.4.1 Erytech Details
2.4.2 Erytech Major Business
2.4.3 Erytech SWOT Analysis
2.4.4 Erytech Product and Services
2.4.5 Erytech Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Fate Therapeutics
2.5.1 Fate Therapeutics Details
2.5.2 Fate Therapeutics Major Business
2.5.3 Fate Therapeutics SWOT Analysis
2.5.4 Fate Therapeutics Product and Services
2.5.5 Fate Therapeutics Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Seta Clinic Group
2.6.1 Seta Clinic Group Details
2.6.2 Seta Clinic Group Major Business
2.6.3 Seta Clinic Group Product and Services
2.6.4 Seta Clinic Group Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Osiris
2.7.1 Osiris Details
2.7.2 Osiris Major Business
2.7.3 Osiris Product and Services
2.7.4 Osiris Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Oxford BioTherapeutics
2.8.1 Oxford BioTherapeutics Details
2.8.2 Oxford BioTherapeutics Major Business
2.8.3 Oxford BioTherapeutics Product and Services
2.8.4 Oxford BioTherapeutics Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 SBI Holdings
2.9.1 SBI Holdings Details
2.9.2 SBI Holdings Major Business
2.9.3 SBI Holdings Product and Services
2.9.4 SBI Holdings Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Product and Services
2.10.4 Novartis Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Golden Meditech
2.11.1 Golden Meditech Details
2.11.2 Golden Meditech Major Business
2.11.3 Golden Meditech Product and Services
2.11.4 Golden Meditech Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Vericel Corporation
2.12.1 Vericel Corporation Details
2.12.2 Vericel Corporation Major Business
2.12.3 Vericel Corporation Product and Services
2.12.4 Vericel Corporation Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Guanhao Biotech
2.13.1 Guanhao Biotech Details
2.13.2 Guanhao Biotech Major Business
2.13.3 Guanhao Biotech Product and Services
2.13.4 Guanhao Biotech Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Beike Biotechnology
2.14.1 Beike Biotechnology Details
2.14.2 Beike Biotechnology Major Business
2.14.3 Beike Biotechnology Product and Services
2.14.4 Beike Biotechnology Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.15 Fujifilm Cellular Dynamics
2.15.1 Fujifilm Cellular Dynamics Details
2.15.2 Fujifilm Cellular Dynamics Major Business
2.15.3 Fujifilm Cellular Dynamics Product and Services
2.15.4 Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.16 Beroni Group
2.16.1 Beroni Group Details
2.16.2 Beroni Group Major Business
2.16.3 Beroni Group Product and Services
2.16.4 Beroni Group Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.17 JCR Pharmaceuticals
2.17.1 JCR Pharmaceuticals Details
2.17.2 JCR Pharmaceuticals Major Business
2.17.3 JCR Pharmaceuticals Product and Services
2.17.4 JCR Pharmaceuticals Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Immuno-Cell Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Immuno-Cell Therapy Players Market Share
3.2.2 Top 10 Immuno-Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Immuno-Cell Therapy Revenue and Market Share by Regions
4.2 North America Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
5 North America Immuno-Cell Therapy Revenue by Countries
5.1 North America Immuno-Cell Therapy Revenue by Countries (2015-2020)
5.2 USA Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
6 Europe Immuno-Cell Therapy Revenue by Countries
6.1 Europe Immuno-Cell Therapy Revenue by Countries (2015-2020)
6.2 Germany Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
6.4 France Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Immuno-Cell Therapy Revenue by Countries
7.1 Asia-Pacific Immuno-Cell Therapy Revenue by Countries (2015-2020)
7.2 China Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
7.5 India Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
8 South America Immuno-Cell Therapy Revenue by Countries
8.1 South America Immuno-Cell Therapy Revenue by Countries (2015-2020)
8.2 Brazil Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Immuno-Cell Therapy by Countries
9.1 Middle East & Africa Immuno-Cell Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Immuno-Cell Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Immuno-Cell Therapy Market Forecast by Type (2019-2024)
10.3 Passive Immune (NK, LAK etc) Revenue Growth Rate (2015-2025)
10.4 Active Immune Revenue Growth Rate (2015-2025)
11 Global Immuno-Cell Therapy Market Segment by Application
11.1 Global Immuno-Cell Therapy Revenue Market Share by Application (2015-2020)
11.2 Immuno-Cell Therapy Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Cardiovascular Disease (CVD) Revenue Growth (2015-2020)
11.5 Orthopedic Revenue Growth (2015-2020)
11.6 Wound Healing Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Immuno-Cell Therapy Market Size Forecast (2021-2025)
12.1 Global Immuno-Cell Therapy Market Size Forecast (2021-2025)
12.2 Global Immuno-Cell Therapy Market Forecast by Regions (2021-2025)
12.3 North America Immuno-Cell Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Immuno-Cell Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Immuno-Cell Therapy Revenue Market Forecast (2021-2025)
12.6 South America Immuno-Cell Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Immuno-Cell Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Immuno-Cell Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Immuno-Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Immuno-Cell Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Immuno-Cell Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Immuno-Cell Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. MEDINET Co Corporate Information, Location and Competitors
Table 7. MEDINET Co Immuno-Cell Therapy Major Business
Table 8. MEDINET Co Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 9. MEDINET Co SWOT Analysis
Table 10. MEDINET Co Immuno-Cell Therapy Product and Solutions
Table 11. MEDINET Co Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Gilead Sciences Corporate Information, Location and Competitors
Table 13. Gilead Sciences Immuno-Cell Therapy Major Business
Table 14. Gilead Sciences Immuno-Cell Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Gilead Sciences SWOT Analysis
Table 16. Gilead Sciences Immuno-Cell Therapy Product and Solutions
Table 17. Gilead Sciences Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Takeda Corporate Information, Location and Competitors
Table 19. Takeda Immuno-Cell Therapy Major Business
Table 20. Takeda Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 21. Takeda SWOT Analysis
Table 22. Takeda Immuno-Cell Therapy Product and Solutions
Table 23. Takeda Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Erytech Corporate Information, Location and Competitors
Table 25. Erytech Immuno-Cell Therapy Major Business
Table 26. Erytech Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Erytech SWOT Analysis
Table 28. Erytech Immuno-Cell Therapy Product and Solutions
Table 29. Erytech Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Fate Therapeutics Corporate Information, Location and Competitors
Table 31. Fate Therapeutics Immuno-Cell Therapy Major Business
Table 32. Fate Therapeutics Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Fate Therapeutics SWOT Analysis
Table 34. Fate Therapeutics Immuno-Cell Therapy Product and Solutions
Table 35. Fate Therapeutics Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Seta Clinic Group Corporate Information, Location and Competitors
Table 37. Seta Clinic Group Immuno-Cell Therapy Major Business
Table 38. Seta Clinic Group Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 39. Seta Clinic Group SWOT Analysis
Table 40. Seta Clinic Group Immuno-Cell Therapy Product and Solutions
Table 41. Seta Clinic Group Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Osiris Corporate Information, Location and Competitors
Table 43. Osiris Immuno-Cell Therapy Major Business
Table 44. Osiris Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 45. Osiris SWOT Analysis
Table 46. Osiris Immuno-Cell Therapy Product and Solutions
Table 47. Osiris Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Oxford BioTherapeutics Corporate Information, Location and Competitors
Table 49. Oxford BioTherapeutics Immuno-Cell Therapy Major Business
Table 50. Oxford BioTherapeutics Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 51. Oxford BioTherapeutics SWOT Analysis
Table 52. Oxford BioTherapeutics Immuno-Cell Therapy Product and Solutions
Table 53. Oxford BioTherapeutics Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. SBI Holdings Corporate Information, Location and Competitors
Table 55. SBI Holdings Immuno-Cell Therapy Major Business
Table 56. SBI Holdings Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 57. SBI Holdings SWOT Analysis
Table 58. SBI Holdings Immuno-Cell Therapy Product and Solutions
Table 59. SBI Holdings Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Novartis Corporate Information, Location and Competitors
Table 61. Novartis Immuno-Cell Therapy Major Business
Table 62. Novartis Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 63. Novartis SWOT Analysis
Table 64. Novartis Immuno-Cell Therapy Product and Solutions
Table 65. Novartis Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Golden Meditech Corporate Information, Location and Competitors
Table 67. Golden Meditech Immuno-Cell Therapy Major Business
Table 68. Golden Meditech Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 69. Golden Meditech SWOT Analysis
Table 70. Golden Meditech Immuno-Cell Therapy Product and Solutions
Table 71. Golden Meditech Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Vericel Corporation Corporate Information, Location and Competitors
Table 73. Vericel Corporation Immuno-Cell Therapy Major Business
Table 74. Vericel Corporation Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 75. Vericel Corporation SWOT Analysis
Table 76. Vericel Corporation Immuno-Cell Therapy Product and Solutions
Table 77. Vericel Corporation Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Guanhao Biotech Corporate Information, Location and Competitors
Table 79. Guanhao Biotech Immuno-Cell Therapy Major Business
Table 80. Guanhao Biotech Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 81. Guanhao Biotech SWOT Analysis
Table 82. Guanhao Biotech Immuno-Cell Therapy Product and Solutions
Table 83. Guanhao Biotech Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Beike Biotechnology Corporate Information, Location and Competitors
Table 85. Beike Biotechnology Immuno-Cell Therapy Major Business
Table 86. Beike Biotechnology Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 87. Beike Biotechnology SWOT Analysis
Table 88. Beike Biotechnology Immuno-Cell Therapy Product and Solutions
Table 89. Beike Biotechnology Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Fujifilm Cellular Dynamics Corporate Information, Location and Competitors
Table 91. Fujifilm Cellular Dynamics Immuno-Cell Therapy Major Business
Table 92. Fujifilm Cellular Dynamics Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 93. Fujifilm Cellular Dynamics SWOT Analysis
Table 94. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product and Solutions
Table 95. Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Beroni Group Corporate Information, Location and Competitors
Table 97. Beroni Group Immuno-Cell Therapy Major Business
Table 98. Beroni Group Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 99. Beroni Group SWOT Analysis
Table 100. Beroni Group Immuno-Cell Therapy Product and Solutions
Table 101. Beroni Group Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. JCR Pharmaceuticals Corporate Information, Location and Competitors
Table 103. JCR Pharmaceuticals Immuno-Cell Therapy Major Business
Table 104. JCR Pharmaceuticals Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 105. JCR Pharmaceuticals SWOT Analysis
Table 106. JCR Pharmaceuticals Immuno-Cell Therapy Product and Solutions
Table 107. JCR Pharmaceuticals Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Global Immuno-Cell Therapy Revenue (Million USD) by Players (2015-2020)
Table 109. Global Immuno-Cell Therapy Revenue Share by Players (2015-2020)
Table 110. Global Immuno-Cell Therapy Revenue (Million USD) by Regions (2015-2020)
Table 111. Global Immuno-Cell Therapy Revenue Market Share by Regions (2015-2020)
Table 112. North America Immuno-Cell Therapy Revenue by Countries (2015-2020)
Table 113. North America Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 114. Europe Immuno-Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 115. Asia-Pacific Immuno-Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 116. South America Immuno-Cell Therapy Revenue by Countries (2015-2020)
Table 117. South America Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 118. Middle East and Africa Immuno-Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 119. Middle East and Africa Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 120. Global Immuno-Cell Therapy Revenue (Million USD) by Type (2015-2020)
Table 121. Global Immuno-Cell Therapy Revenue Share by Type (2015-2020)
Table 122. Global Immuno-Cell Therapy Revenue Forecast by Type (2021-2025)
Table 123. Global Immuno-Cell Therapy Revenue by Application (2015-2020)
Table 124. Global Immuno-Cell Therapy Revenue Share by Application (2015-2020)
Table 125. Global Immuno-Cell Therapy Revenue Forecast by Application (2021-2025)
Table 126. Global Immuno-Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Immuno-Cell Therapy Picture
Figure 2. Global Immuno-Cell Therapy Revenue Market Share by Type in 2019
Figure 3. Passive Immune (NK, LAK etc) Picture
Figure 4. Active Immune Picture
Figure 5. Immuno-Cell Therapy Revenue Market Share by Application in 2019
Figure 6. Oncology Picture
Figure 7. Cardiovascular Disease (CVD) Picture
Figure 8. Orthopedic Picture
Figure 9. Wound Healing Picture
Figure 10. Others Picture
Figure 11. Global Immuno-Cell Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Immuno-Cell Therapy Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Immuno-Cell Therapy Revenue Market Share in 2019
Figure 20. Global Top 10 Players Immuno-Cell Therapy Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Immuno-Cell Therapy Revenue Market Share by Regions (2015-2020)
Figure 24. Global Immuno-Cell Therapy Revenue Market Share by Regions in 2018
Figure 25. North America Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Europe Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 28. South America Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 30. North America Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 31. North America Immuno-Cell Therapy Revenue Market Share by Countries in 2019
Figure 32. USA Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Canada Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 35. Europe Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Immuno-Cell Therapy Revenue Market Share by Countries in 2019
Figure 37. Germany Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 38. UK Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 39. France Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Russia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Italy Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Immuno-Cell Therapy Revenue Market Share by Countries in 2019
Figure 44. China Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Japan Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Korea Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 47. India Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 49. South America Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 50. South America Immuno-Cell Therapy Revenue Market Share by Countries in 2019
Figure 51. Brazil Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Immuno-Cell Therapy Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 56. UAE Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Immuno-Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 59. Global Immuno-Cell Therapy Revenue Share by Type (2015-2020)
Figure 60. Global Immuno-Cell Therapy Revenue Share by Type in 2019
Figure 61. Global Immuno-Cell Therapy Market Share Forecast by Type (2021-2025)
Figure 62. Global Passive Immune (NK, LAK etc) Revenue Growth Rate (2015-2020)
Figure 63. Global Active Immune Revenue Growth Rate (2015-2020)
Figure 64. Global Immuno-Cell Therapy Revenue Share by Application (2015-2020)
Figure 65. Global Immuno-Cell Therapy Revenue Share by Application in 2019
Figure 66. Global Immuno-Cell Therapy Market Share Forecast by Application (2021-2025)
Figure 67. Global Oncology Revenue Growth Rate (2015-2020)
Figure 68. Global Cardiovascular Disease (CVD) Revenue Growth Rate (2015-2020)
Figure 69. Global Orthopedic Revenue Growth Rate (2015-2020)
Figure 70. Global Wound Healing Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Immuno-Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Immuno-Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Immuno-Cell Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Immuno-Cell Therapy Revenue Market Forecast (2021-2025)
Figure 76. Europe Immuno-Cell Therapy Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Immuno-Cell Therapy Revenue Market Forecast (2021-2025)
Figure 78. South America Immuno-Cell Therapy Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Immuno-Cell Therapy Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
免疫細胞療法の世界市場（～2026年） Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body. Market Analysis and Insig…- 変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…
- 多発性骨髄腫に対するCAR-T細胞療法の世界市場（～2026年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…
- 多発性硬化症における幹細胞治療の世界市場（～2026年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…